Pulmonary arterial hypertension: Epidemiology and registries

Journal of the American College of Cardiology

Volumn 62, Issue 25 SUPPL., 2013, Pages

  McGoon, Michael D ^a   Benza, Raymond L ^b   Escribano Subias, Pilar ^c   Jiang, Xin ^d   Miller, Dave P ^e   Peacock, Andrew J ^f   Pepke Zaba, Joanna ^g   Pulido, Tomas ^h   Rich, Stuart ⁱ   Rosenkranz, Stephan ^j   Suissa, Samy ^k   Humbert, Marc ^l  

^a MAYO CLINIC   (United States)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

^c Hospital Universitario   (Spain)

^d FUWAI HOSPITAL   (China)

^e ICON CLINICAL RESEARCH   (United States)

^f Scottish Pulmonary Vascular Unit   (United Kingdom)

^g PAPWORTH HOSPITAL   (United Kingdom)

^h NATIONAL HEART INSTITUTE   (Mexico)

ⁱ UNIVERSITY OF CHICAGO   (United States)

^j UNIVERSITY OF COLOGNE   (Germany)

^k MCGILL UNIVERSITY   (Canada)

^l UNIVERSITÉ PARIS SACLAY   (France)

more..

Author keywords

databases; epidemiology; pulmonary hypertension; registries

Indexed keywords

ACCESS TO INFORMATION; AGE DISTRIBUTION; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CONFERENCE PAPER; DISEASE CLASSIFICATION; DISEASE REGISTRY; HUMAN; INFORMATION PROCESSING; INFORMATION RETRIEVAL; MEDICAL INFORMATION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; SURVIVAL RATE;

6-MIN WALK DISTANCE; 6MWD; CASE REPORT FORM; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CRF; CTEPH; DATABASES; EPIDEMIOLOGY; NATIONAL INSTITUTES OF HEALTH; NIH; PAH; PH; PPH; PRIMARY PULMONARY HYPERTENSION; PULMONARY ARTERIAL HYPERTENSION; PULMONARY HYPERTENSION; REGISTRIES;

ANIMALS; HUMANS; HYPERTENSION, PULMONARY; PREDICTIVE VALUE OF TESTS; REGISTRIES;

EID: 84890722680     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.10.023     Document Type: Conference Paper

References (55)

1. R.E. Gliklich, and N.A. Dreyer Registries for Evaluating Patient Outcomes: A User's Guide. (Prepared by Outcome DEcIDE Center [Outcome Sciences, Inc. d/b/a Outcome] under Contract No. HHSA29020050035I TO3) 2nd edition 2010 Agency for Healthcare Research and Quality Rockville, MD
2. European Medicines Agency. Guidelines on Pharmacovigilance for Medicinal Products for Human Use. Available at: http://ec.europa.eu/health/documents/ eudralex/vol-9/index-en.htm. Accessed November 6, 2013.
3. N.A. Dreyer, S. Schneeweiss, and B.J. McNeil GRACE Principles: Recognizing High-Quality Observational Studies of Comparative Effectiveness Am J Manag Care 16 2010 467 471
4. S. Suissa Immortal time bias in pharmacoepidemiology Am J Epidemiol 167 2008 492 499
5. D.B. Rubin Multiple imputation after 18+ years (with discussion) J Am Stat Assoc 91 1996 473 489
6. W.T. Lee, Y. Ling, K.K. Sheares, J. Pepke-Zaba, A.J. Peacock, and M.K. Johnson Predicting survival in pulmonary arterial hypertension in the UK Eur Respir J 40 2012 604 611
7. D.P. Miller, M. Gomberg-Maitland, and M. Humbert Survivor bias and risk assessment Eur Respir J 40 2012 530 532
8. M.D. McGoon, A. Krichman, and H. Farber Design of the REVEAL Registry for US Patients with Pulmonary Arterial Hypertension Mayo Clin Proc 83 2008 923 931
9. M. Humbert, O. Sitbon, and A. Chaouat Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era Circulation 122 2010 156 163
10. R.L. Benza, D.P. Miller, R.J. Barst, D.B. Badesch, A.E. Frost, and M.D. McGoon An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry Chest 142 2012 448 456
11. M.D. McGoon, and D.P. Miller REVEAL: a contemporary US pulmonary arterial hypertension registry Eur Respir Rev 21 2012 8 18
12. A.E. Frost, H.W. Farber, R.J. Barst, D.P. Miller, C.G. Elliott, and M.D. McGoon Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures of 16-18 mmHg: insights from REVEAL Chest 143 2013 185 195
13. International Society for Pharmacoepidemiology (ISPE) Guidelines for good pharmacoepidemiology practices (GPP) Pharmacoepidemiol Drug Saf 17 2008 200 208
14. E. von Elm, D.G. Altman, M. Egger, S.J. Pocock, P.C. Gøtzsche, and J.P. Vandenbroucke STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies PLoS Med 4 2007 e296
15. M. Levine, and J. Julian Registries that show efficacy: good, but not good enough J Clin Oncol 26 2008 5316 5319
16. J.P. Vandenbroucke, and B.M. Psaty Benefits and risks of drug treatments: how to combine the best evidence on benefits with the best data about adverse effects JAMA 300 2008 2417 2419
17. G.E. D'Alonzo, R.J. Barst, and S.M. Ayres Survival in patients with primary pulmonary hypertension: results from a national prospective registry Ann Intern Med 115 1991 343 349
18. S. Rich, D.R. Dantzker, and S.M. Ayres Primary pulmonary hypertension: a national prospective study Ann Intern Med 107 1987 216 223
19. T. Thenappan, S.J. Shah, S. Rich, L. Tian, S.L. Archer, and M. Gomberg-Maitland Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation Eur Respir J 35 2010 1079 1087
20. A.J. Peacock, N.F. Murphy, J.J.V. McMurray, L. Caballero, and S. Stewart An epidemiological study of pulmonary arterial hypertension Eur Respir J 30 2007 104 109
21. M. Humbert, O. Sitbon, and A. Yaici Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension Eur Respir J 36 2010 549 555
22. M. Humbert, O. Sitbon, and A. Chaouat Pulmonary arterial hypertension in France: results from a national registry Am J Respir Crit Care Med 173 2006 1023 1030
23. Z.-C. Jing, X.-Q. Xu, and Z.-Y. Han Registry and survival study in Chinese patients with idiopathic and familial pulmonary arterial hypertension Chest 132 2007 373 379
24. D.B. Badesch, G.E. Raskob, and C.G. Elliott Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry Chest 137 2010 376 387
25. R.J. Barst, M.D. McGoon, C.G. Elliott, A.J. Foreman, D.P. Miller, and D.D. Ivy Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management Circulation 125 2012 113 122
26. R.L. Benza, D.P. Miller, A. Frost, R.J. Barst, A.M. Krichman, and M.D. McGoon Analysis of the lung allocation score estimation of risk of death in patients with pulmonary arterial hypertension using data from the REVEAL Registry Transplantation 90 2010 298 305
27. R.L. Benza, D.P. Miller, and M. Gomberg-Maitland Predicting survival in pulmonary arterial hypertension. Insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) Circulation 122 2010 164 172
28. L.M. Brown, H. Chen, and S. Halpern Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry Chest 140 2011 19 26
29. L. Chung, J. Liu, and L. Parsons Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype Chest 138 2010 1383 1394
30. H.W. Farber, A.J. Foreman, D.P. Miller, and M.D. McGoon REVEAL Registry: correlation of right heart catheterization and echocardiography in patients with pulmonary arterial hypertension Congest Heart Fail 17 2011 56 64
31. A.E. Frost, D.B. Badesch, and R.J. Barst The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US contemporary registries Chest 139 2011 128 137
32. M.J. Krowka, D.P. Miller, and R.J. Barst Portopulmonary hypertension: a report from the US-based REVEAL Registry Chest 141 2012 906 915
33. S. Shapiro, G.L. Traiger, M. Turner, M.D. McGoon, P. Wason, and R.J. Barst Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease management Chest 141 2012 363 373
34. P. Escribano-Subias, I. Blanco, and M. Lopez-Meseguer Survival in pulmonary hypertension in Spain: insights from the Spanish registry Eur Respir J 40 2012 596 603
35. Y. Ling, M.K. Johnson, and D.G. Kiely Changing demographics, epidemiology and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland Am J Respir Crit Care Med 186 2012 790 796
36. X. Jiang, M. Humbert, and Z.C. Jing Idiopathic pulmonary arterial hypertension and its prognosis in the modern management era in developed and developing countries M. Humbert, R. Souza, G. Simonneau, Pulmonary Vascular Disorders. Prog Respir Res 2012 Karger Basel 85 93
37. R. Zhang, L.Z. Dai, and W.P. Xie Survival of Chinese patients with pulmonary arterial hypertension in the modern management era Chest 140 2011 301 309
38. G.C. Kane, H. Maradit-Kremers, J.P. Slusser, C.G. Scott, R.P. Frantz, and M.D. McGoon Integration of clinical and hemodynamic parameters in the prediction of long-term survival in patients with pulmonary arterial hypertension Chest 139 2011 1285 1293
39. M.M. Hoeper, D. Huscher, and H.A. Ghofrani Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry Int J Cardiol 168 2013 871 880
40. R.L. Benza, M. Gomberg-Maitland, and D.P. Miller The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension Chest 141 2012 354 362
41. M. Delgado-Rodriguez, and J. Llorca Bias J Epidemiol Commun Health 58 2004 635 641
42. E.G. Campbell, R.L. Gruen, J. Mountford, L.G. Miller, P.D. Cleary, and D. Blumenthal A national survey of physician-industry relationships N Engl J Med 356 2007 1742 1750
43. E. Bossone, B.D. Bodini, A. Mazza, and L. Allegra Pulmonary arterial hypertension-the key role of echocardiography Chest 127 2005 1836 1843
44. R. Cogswell, E. Kobashigawa, D. McGlothlin, R. Shaw, and T. De Marco Validation of the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) pulmonary hypertension prediction model in a unique population and utility in the prediction of long-term survival J Heart Lung Transplant 31 2012 1165 1170
45. R. Cogswell, D. McGlothlin, E. Kobashigawa, R. Shaw, and T. De Marco Performance of the REVEAL model in WHO Group 2 to 5 pulmonary hypertension: application beyond pulmonary arterial hypertension J Heart Lung Transplant 32 2013 293 298
46. M. McGoon, R. Benza, and A. Frost External validation of the French predictive model to estimate PAH survival: a REVEAL® analysis (abstr) Eur Respir J 40 2012 41S
47. O. Sitbon, M. Humbert, and G. Simonneau External validation of the REVEAL risk score calculator for PAH survival: a French pulmonary hypertension network analysis (abstr) Eur Respir J 40 2012 41S
48. J. Hurdman, R. Condliffe, and C.A. Elliot ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre Eur Respir J 39 2012 945 955
49. J. Hurdman, R. Condliffe, and C.A. Elliot Pulmonary hypertension in COPD: results from the ASPIRE registry Eur Respir J 41 2012 292 301
50. J. Pepke-Zaba, M. Delcroix, and I. Lang Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry Circulation 124 2011 1973 1981
51. M. Gomberg-Maitland, and E.D. Michelakis A global pulmonary arterial hypertension registry: is it needed? Is it feasible? Pulmonary vascular disease: the global perspective Chest 137 2010 95S 101S
52. M. Beghetti, R.M.F. Berger, and I. Schulze-Neick Diagnostic evaluation of paediatric pulmonary hypertension in current clinical practice Eur Respir J 42 2013 689 700
53. R.M. Berger, M. Beghetti, and T. Humpl Clinical features of paediatric pulmonary hypertension: a registry study Lancet 379 2012 537 546
54. G. Hansmann, and M.M. Hoeper Registries for paediatric pulmonary hypertension Eur Respir J 42 2013 580 583
55. M. Humbert, E.S. Segal, D.G. Kiely, J. Carlsen, B. Schwierin, and M.M. Hoeper Results of European post-marketing surveillance of bosentan in pulmonary hypertension Eur Respir J 30 2007 228 244